Literature DB >> 20534023

Early discharge from a neonatal intensive care unit and rates of readmission.

Kazuo Seki1, Shiho Iwasaki, Hiromi An, Haruko Horiguchi, Masaaki Mori, Shigeru Nishimaki, Shumpei Yokota.   

Abstract

BACKGROUND: Increasing admissions to neonatal intensive care units (NICUs) demand early discharge from the units. Our hospital aims to early discharge patients who meet the following requirements: they are able to regulate body temperature; neither apnea nor bradycardia is observed; and bodyweight increases with lactation. We studied the real state of this strategy.
METHODS: We looked at postmenstrual age, bodyweight, complication at the time of discharge and the readmission rate in 609 patients with gestational age of less than 34 weeks, who were discharged from our NICU between January 2000 and March 2008.
RESULTS: The postmenstrual age and bodyweight at discharge decreased with the increase of gestational age. This tendency was stronger in cases with gestational age of less than 26 weeks. A comparison was made between two patient groups with a gestational age of less than 26 weeks and with the age of 26 weeks or longer. Many patients with a gestational age of less than 26 weeks suffered frequently from complications and were on home oxygen therapy. The readmission rates within 3 months and 1 year of NICU discharge were 10.4% and 26.9% in patients with gestational age between 22 and 25 weeks, respectively, while those rates were 2.8% and 7.4% in patients with gestational weeks of 26 to 34, respectively.
CONCLUSION: The postmenstrual age and bodyweight at NICU discharge decreased in inverse proportion to gestational age, especially less than 26 weeks. Our requirements for early discharge were verified by the readmission rate in this investigation.
© 2011 The Authors. Pediatrics International © 2011 Japan Pediatric Society.

Entities:  

Mesh:

Year:  2011        PMID: 20534023     DOI: 10.1111/j.1442-200X.2010.03179.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

1.  Initial Treatment of Respiratory Distress Syndrome with Nasal Intermittent Mandatory Ventilation versus Nasal Continuous Positive Airway Pressure: A Randomized Controlled Trial.

Authors:  Amir-Mohammad Armanian; Zohreh Badiee; Ghobad Heidari; Awat Feizi; Nima Salehimehr
Journal:  Int J Prev Med       Date:  2014-12

2.  The Prevalence of Complications of Prematurity among 1000 Newborns in Isfahan, Iran.

Authors:  Amir-Mohammad Armanian; Behzad Barekatain; Fatemeh Sohrabi; Nima Salehimehr; Marjan Mansourian
Journal:  Adv Biomed Res       Date:  2019-02-21

3.  Variations in length of stay among survived very preterm infants admitted to Chinese neonatal intensive care units.

Authors:  Min Zhang; Yan-Chen Wang; Jin-Xing Feng; Ai-Zhen Yu; Jing-Wei Huang; Si-Yuan Jiang; Xin-Yue Gu; Jian-Hua Sun; Yun Cao; Wen-Hao Zhou; Shoo K Lee; Li-Li Wang; Rong Yin
Journal:  World J Pediatr       Date:  2022-01-05       Impact factor: 2.764

4.  The Effect of Empowerment Program on Maternal Discharge Preparation and Neonatal Length of Hospital Stay: A Randomized Controlled Trial.

Authors:  Shahla Moradi; Mohammad Arshdi-Bostanabad; Alehe Seyedrasooli; Lily Tapak; Sousan Valizadeh
Journal:  Iran J Nurs Midwifery Res       Date:  2018 May-Jun

5.  Duration and Time Trends in Hospital Stay for Very Preterm Infants Differ Across European Regions.

Authors:  Rolf F Maier; Béatrice Blondel; Aurélie Piedvache; Bjoern Misselwitz; Stavros Petrou; Patrick Van Reempts; Francesco Franco; Henrique Barros; Janusz Gadzinowski; Klaus Boerch; Arno van Heijst; Elizabeth S Draper; Jennifer Zeitlin
Journal:  Pediatr Crit Care Med       Date:  2018-12       Impact factor: 3.624

6.  Assessing the risk of early unplanned rehospitalisation in preterm babies: EPIPAGE 2 study.

Authors:  Robert Anthony Reed; Andrei Scott Morgan; Jennifer Zeitlin; Pierre-Henri Jarreau; Héloïse Torchin; Véronique Pierrat; Pierre-Yves Ancel; Babak Khoshnood
Journal:  BMC Pediatr       Date:  2019-11-21       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.